Is Alynlam the next breakthrough name in biotechnology? Investors say ‘yes’ – MedCity News
By Dr. Matthew Watson
 Boston Globe | Is Alynlam the next breakthrough name in biotechnology? Investors say 'yes' MedCity News (Reuters) - A radical new treatment for genetic disorders has catapulted Alnylam Pharmaceuticals Inc into the crosshairs of investors seeking the next breakthrough name in biotechnology. The challenge for the Cambridge, Massachusetts-based company ... Stocks to Keep Your Eyes on - Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN ...Techsonian Alnylam Pharmaceuticals (ALNY) Shares Soar After Positive Drug Trial ResultsNew Stuff Here Alnylam Reports Positive Top-Line Results for ALN-TTRsc, a Subcutaneously ...EON: Enhanced Online News (press release) |
Uncategorized
Comments Off on Is Alynlam the next breakthrough name in biotechnology? Investors say ‘yes’ – MedCity News |
July 14th, 2013
This author published 6072 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research